1Pour-Reza-Gholi F, Nafar M, Saeedinia A, et al. Kidney retransplantation incomparison with first kidney transplantation [J]. Transplant Proc,2005,37(7):2951-2964.
2Gjertson DW. A multi-factor analysis of kidney regraft outcomes[J]. Clin Transplant, 2002,8 : 335 - 349.
4Giselao, Broyer M, Niaudet P, et al. A muhicenter, Open-label,pharm-acokinetie/pharmacodynamic safety, and tolerability study of basilixi-mab(Simulect)in pediatric de novo rend transplant recipients [J]. Transplantation, 2003, 74 ( 3 ) : 961 -966.
2Almond P S, Matas A J, Gillingham K, et al. Risk factors for second renal allografts immunosuppressed with cyclosporine [J]. Transplantation, 1991,52(2) : 253-258.
3Takemoto S K, Terasaki P 1, Gjertson D W, et al. Twelve years' experience with national sharing of HLA-matched cadaveric kidneys for transplantation [J]. N Engl J Med,2000, 343(15) : 1078-1084.
4EL-Awar N, Terasaki P, Lazda V, et al. Almost all patients who are waiting for a regraft of a kidney transplant have anti-HLA antibodies [ J ]. Transplant Pine, 2002,34 (7) : 2531-2532.
5Risaliti A, Sainz-Barriga M, Baccarani U, et al. Surgical complications after kidney transplantation [ J ]. G ltal Nefrol, 2004, 21 (Suppl 26) :S43-47.
6Galmes 1, Buegos F J, Borrego J, et al. Vascular complications in renal transplantation [J]. Actas Urol Esp, 1995,19( 1 ) : 8-14.
7Borrego J, Burgos F J, Galmes I, et al. Surgical complications in 479 renal transplantations [ J ]. Actas Urol Esp, 1994,18 (4) : 253 -257.
